Literature DB >> 9353013

A role for pneumolysin but not neuraminidase in the hearing loss and cochlear damage induced by experimental pneumococcal meningitis in guinea pigs.

A J Winter1, S D Comis, M P Osborne, M J Tarlow, J Stephen, P W Andrew, J Hill, T J Mitchell.   

Abstract

We investigated the roles of pneumolysin and neuraminidase in the pathogenesis of deafness and cochlear damage during experimental pneumococcal meningitis. Anesthetized guinea pigs were inoculated intracranially with 7.5 log10 CFU of either (i) wild-type Streptococcus pneumoniae D39 (n = 8), (ii) PLN-A, a defined isogenic derivative of D39 deficient in pneumolysin (n = 5), or (iii) deltaNA1, a new derivative of D39 deficient in neuraminidase constructed by insertion-duplication mutagenesis of the nanA gene (n = 5). To quantify hearing loss, the auditory nerve compound action potential evoked by a tone pulse was recorded from the round window membrane of the cochlea every 3 h for 12 h. The organ of Corti was intravitally fixed for subsequent examination by high-resolution scanning and transmission electron microscopy. All animals sustained similar meningeal inflammatory responses. PLN-A induced significantly less hearing loss than D39 over the frequency range of 3 to 10 kHz. Levels of mean hearing loss at 10 kHz 12 h postinoculation were as follows: D39, 50 dB; deltaNA1, 52 dB (P = 0.76 versus D39), and PLN-A, 12 dB (P < 0.0001 versus D39). The mean rates of hearing loss at 10 kHz were 4.4 dB/h for D39, 4.3 dB/h for deltaNA1, and just 1.0 dB/h for PLN-A (P < 0.0001 versus D39). Suppurative labyrinthitis was universal. PLN-A induced the accumulation of less protein in the cerebrospinal fluid (P = 0.04 versus D39). Infection with D39 and deltaNA1 induced significant damage to the reticular lamina, the sensory hair cells, and supporting cells of the organ of Corti. By contrast, after infection with PLN-A, the organ of Corti appeared virtually intact. Pneumolysin seems to be the principal cause of cochlear damage in this model of meningogenic deafness. No clear pathogenic role was demonstrated for neuraminidase.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9353013      PMCID: PMC175634          DOI: 10.1128/iai.65.11.4411-4418.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  40 in total

1.  Toxicity of pneumococcal neuraminidase.

Authors:  R Kelly; D Greiff
Journal:  Infect Immun       Date:  1970-07       Impact factor: 3.441

2.  The site of the lesion causing hearing loss in bacterial meningitis: a study of experimental streptococcal meningitis in guinea-pigs.

Authors:  R Kay
Journal:  Neuropathol Appl Neurobiol       Date:  1991-12       Impact factor: 8.090

3.  Electrophysiological and morphological changes in the guinea pig cochlea following mechanical trauma to the organ of Corti.

Authors:  A R Cody; D Robertson; G Bredberg; B M Johnston
Journal:  Acta Otolaryngol       Date:  1980 May-Jun       Impact factor: 1.494

4.  Hearing loss during bacterial meningitis.

Authors:  M P Richardson; A Reid; M J Tarlow; P T Rudd
Journal:  Arch Dis Child       Date:  1997-02       Impact factor: 3.791

5.  NG-methyl-L-arginine protects the guinea pig cochlea from the cytotoxic effects of pneumolysin.

Authors:  F R Amaee; S D Comis; M P Osborne
Journal:  Acta Otolaryngol       Date:  1995-05       Impact factor: 1.494

6.  Hearing in the dog as assessed by auditory brainstem evoked potentials.

Authors:  R Kay; A C Palmer; P M Taylor
Journal:  Vet Rec       Date:  1984-01-28       Impact factor: 2.695

7.  Improvement of the splenectomized rat model for overwhelming pneumococcal infection. Standardization of the bacterial inocula.

Authors:  A Alwmark; S Bengmark; P Gullstrand; C Schalén
Journal:  Eur Surg Res       Date:  1981       Impact factor: 1.745

8.  Interaction of pneumolysin-sufficient and -deficient isogenic variants of Streptococcus pneumoniae with human respiratory mucosa.

Authors:  C F Rayner; A D Jackson; A Rutman; A Dewar; T J Mitchell; P W Andrew; P J Cole; R Wilson
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

9.  Ultrastructural damage to the organ of corti during acute experimental Escherichia coli and pneumococcal meningitis in guinea pigs.

Authors:  A J Winter; S Marwick; M Osborne; S Comis; J Stephen; M Tarlow
Journal:  Acta Otolaryngol       Date:  1996-05       Impact factor: 1.494

10.  Dexamethasone therapy for children with bacterial meningitis. Meningitis Study Group.

Authors:  E R Wald; S L Kaplan; E O Mason; D Sabo; L Ross; M Arditi; B L Wiedermann; W Barson; K S Kim; R Yogov
Journal:  Pediatrics       Date:  1995-01       Impact factor: 7.124

View more
  32 in total

1.  Pneumococcal pneumolysin and H(2)O(2) mediate brain cell apoptosis during meningitis.

Authors:  Johann S Braun; Jack E Sublett; Dorette Freyer; Tim J Mitchell; John L Cleveland; Elaine I Tuomanen; Joerg R Weber
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

2.  Reduced release of pneumolysin by Streptococcus pneumoniae in vitro and in vivo after treatment with nonbacteriolytic antibiotics in comparison to ceftriaxone.

Authors:  Annette Spreer; Holger Kerstan; Tobias Böttcher; Joachim Gerber; Alexander Siemer; Gregor Zysk; Timothy J Mitchell; Helmut Eiffert; Roland Nau
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

3.  Evaluation of the virulence of a Streptococcus pneumoniae neuraminidase-deficient mutant in nasopharyngeal colonization and development of otitis media in the chinchilla model.

Authors:  H H Tong; L E Blue; M A James; T F DeMaria
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

4.  Identification of invasive serotype 1 pneumococcal isolates that express nonhemolytic pneumolysin.

Authors:  Lea-Ann S Kirkham; Johanna M C Jefferies; Alison R Kerr; Yu Jing; Stuart C Clarke; Andrew Smith; Tim J Mitchell
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

5.  Streptococcus pneumoniae-induced inhibition of rat ependymal cilia is attenuated by antipneumolysin antibody.

Authors:  Robert A Hirst; Bashir J Mohammed; Timothy J Mitchell; Peter W Andrew; Christopher O'Callaghan
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

6.  Doxycycline reduces mortality and injury to the brain and cochlea in experimental pneumococcal meningitis.

Authors:  Damian N Meli; Roney S Coimbra; Dominik G Erhart; Gerard Loquet; Caroline L Bellac; Martin G Täuber; Ulf Neumann; Stephen L Leib
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

7.  Pneumolysin causes neuronal cell death through mitochondrial damage.

Authors:  Johann S Braun; Olaf Hoffmann; Miriam Schickhaus; Dorette Freyer; Emilie Dagand; Daniela Bermpohl; Tim J Mitchell; Ingo Bechmann; Joerg R Weber
Journal:  Infect Immun       Date:  2007-06-11       Impact factor: 3.441

8.  Endolymphatic sac involvement in bacterial meningitis.

Authors:  Martin Nue Møller; Christian Brandt; Christian Østergaard; Per Caye-Thomasen
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-01-23       Impact factor: 2.503

9.  Pneumolysin is the main inducer of cytotoxicity to brain microvascular endothelial cells caused by Streptococcus pneumoniae.

Authors:  G Zysk; B K Schneider-Wald; J H Hwang; L Bejo; K S Kim; T J Mitchell; R Hakenbeck; H P Heinz
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

10.  The surface-anchored NanA protein promotes pneumococcal brain endothelial cell invasion.

Authors:  Satoshi Uchiyama; Aaron F Carlin; Arya Khosravi; Shannon Weiman; Anirban Banerjee; Darin Quach; George Hightower; Tim J Mitchell; Kelly S Doran; Victor Nizet
Journal:  J Exp Med       Date:  2009-08-17       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.